Lipase inhibitors and GLP-1 receptor agonists are the preferred medications for treating obesity, not secondary to a genetic cause that limits one’s ability to lose weight with diet and exercise alone. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.